Latest Dana-Farber Cancer Institute Stories
New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death.
CAMBRIDGE, Mass., June 24, 2014 /PRNewswire/ -- Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc.
Company continues to engage leading cancer treatment centers to investigate non-invasive methods of cancer mutation detection in order to advance patient care SAN DIEGO, June 16, 2014
National Nonprofit Organization Contributes $1.2 Million to Support Pediatric Cancer Research Projects Nationwide ATLANTA, May 28, 2014 /PRNewswire-USNewswire/ -- Rally Foundation
NEW YORK, April 25, 2014 /PRNewswire/ -- Uniting Against Lung Cancer (UALC), a nonprofit dedicated to funding
The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene.
Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why.
New therapies are needed to prevent and treat respiratory syncytial virus (RSV) – a potentially lethal respiratory infection that can severely affect infants, young children and the elderly.
Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer.
Comprehensive BMT(TM) will deliver an unmatched hematopoietic stem cell transplant (HSCT) data management solution for improved research and reporting SALT LAKE CITY, March 26, 2014 /PRNewswire/